M DapoignySummaryAffiliation: CHU de Clermont-Ferrand Country: France Publications
| Collaborators
|
Detail Information
Publications
[Irritable bowel syndrome: epidemiology/economic burden]M Dapoigny
Service d Hepato Gastroenterologie, Hotel Dieu, 63003 Clermont Ferrand Cedex, France
Gastroenterol Clin Biol 33:S3-8. 2009....
Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind studyMichel Dapoigny
Médecine Digestive, Centre Hospitalier Universitaire CHU Estaing, CHU Clermont Ferrand, Clermont Universite, Inserm UMR 766, 63001 F Clermont Ferrand, France
World J Gastroenterol 18:2067-75. 2012..To assess the effects and safety of Lactobacillus casei rhamnosus LCR35 complete freeze-dried culture (LCR35) in patients suffering from irritable bowel syndrome (IBS)...
Irritable bowel syndrome and the general practionersM Dapoigny
, , 63000 Clermont-Ferrand, France
Dig Liver Dis 37:907-8. 2005
[Constipation in the child and in the adult (with treatment)]Michel Dapoigny
, , 63003 Clermont-Ferrand Cedex
Rev Prat 54:1699-704. 2004
Role of alimentation in irritable bowel syndromeM Dapoigny
Service de Gastroenterologie, Hotel Dieu, Clermont Ferrand, France
Digestion 67:225-33. 2003..Different food items are made responsible for irritable bowel syndrome (IBS) symptoms, but the physiopathology of IBS remains unclear...
Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndromeJ M Sabate
AP HP, Hopital Louis Mourier, Service d Hepato Gastroenterologie, Colombes, and INSERM, U 792, APHP, CHU Ambroise Pare, Montpellier, France
Aliment Pharmacol Ther 28:484-90. 2008..Relationships between pain threshold during rectal distension and both symptoms intensity and alteration in quality of life (QoL) in irritable bowel syndrome (IBS) patients have been poorly evaluated...
Irritable bowel syndrome in France: a common, debilitating and costly disorderMichel Dapoigny
CHU Hotel Dieu, Clermont Ferrand, France
Eur J Gastroenterol Hepatol 16:995-1001. 2004....
Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in ratsSophie Bourdu
, , Clermont-Ferrand, France
Gastroenterology 128:1996-2008. 2005..The CGRP receptor antagonist-induced reduction of colonic hypersensitivity suggests that CGRP receptors may provide a promising target for treatment of IBS...
Quality of life and illness costs in irritable bowel syndromeMagnus Simren
Department of Internal Medicine, Sahlgrenska University Hospital, SE 41345 Goteborg, Sweden
Digestion 69:254-61. 2004..Drawbacks and advantages with existing instruments to assess quality of life and costs were discussed and the clinical and scientific relevance of the current knowledge was assessed. A summary from the meeting is presented in this paper...
[Recommendations for the clinical management and treatment of chronic constipation in adults]Thierry Piche
, Nice
Gastroenterol Clin Biol 31:125-35. 2007
Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli studyCatherine Brun Strang
Novartis Pharma, Rueil Malmaison, Bourg la Reine, France
Eur J Gastroenterol Hepatol 19:1097-103. 2007..To assess the proportion of physician-diagnosed irritable bowel syndrome (IBS) patients who conform to Rome II criteria, and evaluate the impact of IBS on quality of life (QoL) and costs in France...
Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndromeBenoit Coffin
Service d Hepato Gastroenterologie, Hopital Louis Mourier, AP HP, 178 rue des Renouillers, 92700 Colombes
Gastroenterol Clin Biol 28:11-5. 2004..The aim of this prospective survey was to investigate the relationship between intensity of IBS and changes in QoL...
